Loading…
Medical Affairs Strategic Summit East has ended
Simple
Expanded
Grid
By Venue
Track C: MSL and Field Strategy [clear filter]
Wednesday, April 15
 

1:00pm EDT

Track C: Opening Remarks
Speakers
avatar for Howard Berkowitz

Howard Berkowitz

Respiratory and Immunology, MSL, U.S. Field-Based Medical Affairs, Sanofi Genzyme
Howard has been employed in the pharma industry for over 25 years in various roles within Medical Affairs, including 5 years in sales as a clinical science consultant for BI.   His experience includes roles as National Director of Medical Science Liaisons, Regional Medial Science... Read More →

Wednesday April 15, 2020 1:00pm - 1:15pm EDT
  Track C: MSL and Field Strategy

1:15pm EDT

Track C: Build Out MSL Teams: Review the Difference Between U.S. and Ex-U.S. Scenarios
  • Discuss differences in regulations, and the role/understanding of the MA role becomes challenging when dealing with a company based outside of the U.S.
  • Review challenges in approval processes, position requirements and compensations are all difference once you move outside of the U.S. – with that, the process to develop a strong field medical team is slowed down
Speakers
avatar for J. Lynn Bass, Pharm.D

J. Lynn Bass, Pharm.D

Senior Director and Head, Medical Science Liaisons, Mesoblast, LTD

Wednesday April 15, 2020 1:15pm - 1:45pm EDT
  Track C: MSL and Field Strategy

1:45pm EDT

Track C: Panel: How Medical Affairs Can Help Prepare the Market for a New Drug Launch
  • Review how Medical Affairs (including Field Medical) can support market readiness in terms of external stakeholder engagement
Speakers
avatar for Alan Polnariev

Alan Polnariev

MSL, Ferring Pharmaceutical
Before becoming a Medical Science Liaison five years ago, Dr. Alan Polnariev spent nearly a decade as a clinical pharmacist for the Veterans Affairs Health Care System in several capacities, including their Pharmacy Benefits Management department. During his time at the VA, he received... Read More →
TB

Tommy Brock

Senior MSL, United Therapeutics
avatar for Josh Yoder, Ph.D.

Josh Yoder, Ph.D.

Medical Science Liaison, uniQure
avatar for Luchy Hidalgo, M.D.

Luchy Hidalgo, M.D.

Medical Science Liaison; Medical Affairs Consultant - KOL Insights, Exact Sciences
As a Medical Doctorate graduate of Universidad Autonoma de Santo Domingo, I completed a medical internship in my home country of the Dominican Republic and soon thereafter worked for a year in clinical research at the University of Massachusetts. Next, I joined the Pharma/Medical... Read More →

Wednesday April 15, 2020 1:45pm - 2:15pm EDT
  Track C: MSL and Field Strategy

2:15pm EDT

Track C: Manage MSL Teams within the Evolving Health Care Environment
  • Review the growing sophistication of pharmaceutical products, particularly genomics and orphan drugs, contributes to the increased need for MSLs with specialized scientific knowledge
  • Discuss the evolution of MSL strategies that continue to meet the needs of patients and health care professionals, as the healthcare environment changes
  • Identify new targets of influence and integration of technology and training to enhance scientific interactions through territory management
  • Demonstrate MSL value through documented outcomes and insights which influence strategy will be the key to growth
Speakers
avatar for Peter Ishak

Peter Ishak

Senior Medical Science Liaison, Daiichi Sankyo
Peter was born and raised in New Brunswick, NJ. He attended USciences, Philadelphia College of Pharmacy earning his Pharm.D. Upon graduation, he worked in the community pharmacy setting before going into the pharmaceutical industry. Prior to his current role as a Medical Science Liaison... Read More →

Wednesday April 15, 2020 2:15pm - 2:45pm EDT
  Track C: MSL and Field Strategy

3:15pm EDT

Track C: Use Data Mining Techniques to Enhance Customer Engagement
  • How analytics drive your outreach strategy
  • Segment customer base and target them using data analytics
Speakers
avatar for Ariel Katz

Ariel Katz

CEO, H1
Ariel started his first company in college, ResearchConnection, to help connect students with research opportunities. That company grew to over 40 universities and was eventually acquired by the Bill and Melinda Gates Foundation and the Ewing Kauffman Foundation.Next Ariel started... Read More →
avatar for Dan Hennessy

Dan Hennessy

Vice President, Field MA, EMD Serono
Dan Hennessy, PhD, MS, MBA, is a VP of Strategic Excellence, North America Medical Affairs at EMD Serono and has over 18 years track record of significant contributions to medical affairs and clinical development of hematology/oncology and other specialty drug therapies. Specifically... Read More →

Wednesday April 15, 2020 3:15pm - 3:45pm EDT
  Track C: MSL and Field Strategy

3:45pm EDT

Track C: Utilize Unbranded Scientific Exchange Programs to Ensure Effective Decision-Making
  • Discuss how your team can proactively engage customers through unbranded exchange programs
  • Ensure that you are clearly separating scientific exchange from promotional messaging
  • Use scientific and data-driven information to help HCPs make informed patient-care decisions
Wednesday April 15, 2020 3:45pm - 4:15pm EDT
  Track C: MSL and Field Strategy

4:15pm EDT

Track C: Empowering Medical Science Liaison (MSL) Field Teams
  • Are you maximizing the impact of your MSL Field Teams?
  • WHy are MSL-KOL engagement skills key to a successful launch?
Wednesday April 15, 2020 4:15pm - 4:45pm EDT
  Track C: MSL and Field Strategy
 
Thursday, April 16
 

9:00am EDT

Track C: Opening Remarks
Speakers
avatar for Howard Berkowitz

Howard Berkowitz

Respiratory and Immunology, MSL, U.S. Field-Based Medical Affairs, Sanofi Genzyme
Howard has been employed in the pharma industry for over 25 years in various roles within Medical Affairs, including 5 years in sales as a clinical science consultant for BI.   His experience includes roles as National Director of Medical Science Liaisons, Regional Medial Science... Read More →

Thursday April 16, 2020 9:00am - 9:15am EDT
  Track C: MSL and Field Strategy

9:15am EDT

Track C: Panel: Dissemination of Off Label Information in a Compliant Manner
  • Explore the distinction between solicited and unsolicited queries and discuss regulatory expectations for medical affairs teams
  • Clarify how to provide scientific research and medical findings that are clearly nonpromotional
  • Develop tools and techniques to provide ethical, accurate and balanced off-label data while adding patient value in a compliant manner
Moderators
avatar for Peter Lee

Peter Lee

Vice President, Chief Compliance Officer, Heron Therapeutics, Inc.
Peter Lee received his B.A. from the University of Michigan and his J.D. from Quinnipiac Law School. He has a master’s in health law from Loyola University of Chicago and almost 20 years of experience building compliance programs in healthcare for hospitals, managed care organizations... Read More →

Speakers
avatar for Anna Vichiendilokkul, PharmD MS

Anna Vichiendilokkul, PharmD MS

Director, Medical Science Liaison, GlaxoSmithKline
avatar for Jacqueline S. Armani, OD, FAAO, MSL-BC

Jacqueline S. Armani, OD, FAAO, MSL-BC

Regional MSL Lead – North East, Medical Science Liaison – Metro NY and NJ, Clinical Development and Medical Affairs, North America, Alcon
Jacqueline graduated from the CUNY Honors College (now known as Macaulay Honors) at the College of Staten Island in 2006. She continued her graduate degree at the New England College of Optometry, externed at Bascom Palmer and did her residency at the VA as a primary care and ocular... Read More →
avatar for Teresa P.M. Kelton, JD, PharmD, MPH

Teresa P.M. Kelton, JD, PharmD, MPH

Executive Director, R&D and Quality Counsel, Alexion Pharmaceuticals, Inc.

Thursday April 16, 2020 9:15am - 9:45am EDT
  Track C: MSL and Field Strategy

9:45am EDT

Track C: How to Effectively Collect and Synthesize MSL Insights
  • Understand organizational and key internal stakeholder needs
  • Discuss best practices for the collection of insights
  • Effective synthesis and prioritization of novel insights
Speakers
avatar for Nikki Irish

Nikki Irish

Director of MSL, MA, Adamas Pharmaceuticals

Thursday April 16, 2020 9:45am - 10:15am EDT
  Track C: MSL and Field Strategy

10:45am EDT

Track C: Build the MSL Career Path with a Focus on Facilitating Team Retention
  • Discuss how to facilitate career growth and create advancement opportunities
  • Improve team morale and engagement through team-building strategies and exercises
  • Work with internal and external stakeholders to demonstrate the value of the MSL team
Thursday April 16, 2020 10:45am - 11:15am EDT
  Track C: MSL and Field Strategy

11:15am EDT

Track C: Discuss the Implementation of Digital Strategy for Field MSLs
  • Understand how the use of digital technology can enhance field medical professionals’ processes efficiently and compliantly
  • Ensure field medical teams are connected towards the digital strategy through a seamless strategy roll-out
  • Look at the positives and negatives of integrating digital technologies into field medical’s daily operations
Thursday April 16, 2020 11:15am - 11:45am EDT
  Track C: MSL and Field Strategy

12:45pm EDT

Track B: Panel: Communication Strategies: A Guide to Meaningful Conversations with HCPs, KOLs, Patients, Colleagues and Other Stakeholders
  • How to generate valuable insights and discuss prompted versus unprompted insights
  • How to bring value and focus of the company to KOLs
  • How to bring back insights that provide guidance on publications, educational modules, and developing strategies
  • Clarify technology challenges (such as online/social versus in-person), and review how you may leverage this technology
Moderators
avatar for Nikki Irish

Nikki Irish

Director of MSL, MA, Adamas Pharmaceuticals

Speakers
avatar for Howard Berkowitz

Howard Berkowitz

Respiratory and Immunology, MSL, U.S. Field-Based Medical Affairs, Sanofi Genzyme
Howard has been employed in the pharma industry for over 25 years in various roles within Medical Affairs, including 5 years in sales as a clinical science consultant for BI.   His experience includes roles as National Director of Medical Science Liaisons, Regional Medial Science... Read More →
avatar for Sheila Komara

Sheila Komara

Senior MSL, Mallinckrodt Pharmaceuticals
Has been working in Medical Affairs for 20 years in a variety of roles as a Sr. Medical Science Liaison as well as a Regional Scientific Manager. Expertise includes Hepatology, Critical Care, Sedation, Delirium and Pain Management. Launching several drugs and working with late stage... Read More →
avatar for Keely Dahl

Keely Dahl

Medical Science Liaison, Aurinia Pharmaceuticals Inc.

Thursday April 16, 2020 12:45pm - 1:15pm EDT
  Track C: MSL and Field Strategy

1:15pm EDT

Track C: Panel: Provide a Compliance Perspective on Effective Advisory Board and Consulting Agreement Execution
  • Consider the legal and regulatory risks involved
  • Explore the need for compliance monitoring in advisory boards
  • Discuss the difference in perspectives between medical and commercial groups
Speakers
avatar for Peter Lee

Peter Lee

Vice President, Chief Compliance Officer, Heron Therapeutics, Inc.
Peter Lee received his B.A. from the University of Michigan and his J.D. from Quinnipiac Law School. He has a master’s in health law from Loyola University of Chicago and almost 20 years of experience building compliance programs in healthcare for hospitals, managed care organizations... Read More →

Thursday April 16, 2020 1:15pm - 1:45pm EDT
  Track C: MSL and Field Strategy

1:45pm EDT

Track C: The Ever-Elusive Balance of Quantity vs. Quality in MSL Goals and Metrics
  • Outline what the key activities or goals of MSLs should be in this ever-changing role
  • Review how we measure the success of those goals and ultimately the MSL
  • Discuss whether metrics are the same as goals and how to balance quantity versus quality
  • Determine what a valuable or ‘quality’ interaction should be and whether different types of events or activities should be weighted differently
Speakers
avatar for Kristin Ryan

Kristin Ryan

Field Director MSL, Medical Affairs, Astellas
Kristin Ryan is the US Field Director for the Astellas Urology Medical Science Liaison (MSL) organization within Medical Affairs.  She has experience in the pharmaceutical industry covering 16 products across five therapeutic areas including devices.  Kristin is a leader known for... Read More →

Thursday April 16, 2020 1:45pm - 2:15pm EDT
  Track C: MSL and Field Strategy

2:15pm EDT

Track C: Closing Remarks
Speakers
avatar for Howard Berkowitz

Howard Berkowitz

Respiratory and Immunology, MSL, U.S. Field-Based Medical Affairs, Sanofi Genzyme
Howard has been employed in the pharma industry for over 25 years in various roles within Medical Affairs, including 5 years in sales as a clinical science consultant for BI.   His experience includes roles as National Director of Medical Science Liaisons, Regional Medial Science... Read More →

Thursday April 16, 2020 2:15pm - 2:30pm EDT
  Track C: MSL and Field Strategy
 
Filter sessions
Apply filters to sessions.
Tuesday, April 14
Wednesday, April 15
Thursday, April 16
  • KOL Seminar
  • Main Conference
  • Networking
  • Track A: Medical Affairs Strategy
  • Track B: Medical Operations & Technology
  • Track C: MSL and Field Strategy
  • Track D: Investigator-Initiated Trials
  • Workshop